PCSK9 inhibitors

Data on investigational cholesterol-lowering meds to be presented at cardiology meeting
Medical Marketing and Media
Thu, 03/12/15 - 10:14 pm
PCSK9 inhibitors
Amgen
Repatha
Exclusive: Regeneron, Sanofi outline promising PhIIb data for top blockbuster pick dupilumab
Fierce Biotech
Mon, 02/23/15 - 08:47 am
Sanofi
Regeneron
dupilumab
PCSK9 inhibitors
No, The New Cholesterol Drugs From Sanofi And Amgen Aren't Going To Cost $150 Billion A Year
Forbes
Thu, 02/19/15 - 07:53 am
Sanofi
Amgen
PCSK9 inhibitors
drug pricing
CVS urges cost controls for new cholesterol, specialty drugs
Yahoo/Reuters
Tue, 02/17/15 - 05:03 pm
CVS
drug pricing
cholesterol
PCSK9 inhibitors
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
Sky-High Genetic Cholesterol Targeted for Blockbuster Drug. Now to Find the Patients
Yahoo/Bloomberg
Fri, 12/5/14 - 10:36 am
cholesterol
familial hypercholesterolemia
PCSK9 inhibitors
What Doctors are Saying About Those New Cholesterol Meds
WSJ Pharmalot
Tue, 09/2/14 - 11:28 am
physicians
PCSK9 inhibitors
statins
Amgen: Why Its New Drug Application is a Big Deal
Barron's
Thu, 08/28/14 - 07:23 pm
Amgen
evolocumab
PCSK9 inhibitors
Amgen submits U.S. application to sell cholesterol-fighting drug
Yahoo/Reuters
Thu, 08/28/14 - 10:28 am
Amgen
PCSK9 inhibitors
evolocumab
As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
First Word Pharma
Wed, 08/6/14 - 10:11 am
cardiologists
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
evolocumab
alirocumab
What's the gleam in Sanofi CEO's eye? Could be Q2--or a canny PCSK9 maneuver
Fierce Pharma
Thu, 07/31/14 - 11:54 am
Chris Viehbacher
Sanofi
earnings
Pharma CEOs
PCSK9 inhibitors
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
immuno-oncology
Sovaldi
Gilead Sciences
Teva Pharmaceuticals
Copaxone
GSK
Breo Ellipta
Forest Labs
Actavis
M&A
Affordable Care Act
biosimilars
PCSK9 inhibitors
Study: New Cholesterol Drugs Effectively Lower LDL Levels
Wall St Cheat Sheet
Tue, 04/1/14 - 08:16 am
cholesterol
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
New Cholesterol Fighters To Take Center Stage At ACC
Investors.com
Fri, 03/28/14 - 10:22 am
cholesterol
Pfizer
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
American Cardiology Conference
alirocumab
FDA Concerns Are the Least of These Drugs' Worries
Motley Fool
Mon, 03/17/14 - 09:53 am
FDA
PCSK9 inhibitors
Regeneron
Sanofi
Merck
alirocumab
With FDA Concerns Public, What's Next for These Cholesterol Drugs?
Motley Fool
Thu, 03/13/14 - 05:55 pm
FDA
Regeneron
Pfizer
Amgen
PCSK9 inhibitors
FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade
Forbes
Sat, 03/8/14 - 10:31 am
PCSK9 inhibitors
Regeneron
Sanofi
hypercholesterolemia
FDA asks Sanofi, Regeneron to assess cholesterol drug's cognitive risks
Yahoo/Reuters
Fri, 03/7/14 - 03:55 pm
Sanofi
FDA
Regeneron
alirocumab
PCSK9 inhibitors
Amgen extends PhIII sweep with more promising results for PCSK9 drug
Fierce Biotech
Wed, 01/29/14 - 10:27 am
Amgen
PCSK9 inhibitors
evolocumab
Amgen cholesterol drug meets goal of third late stage trial
Yahoo/Reuters
Thu, 01/23/14 - 05:53 pm
Amgen
evolocumab
PCSK9 inhibitors

Pages